BATS | ETF
Under normal circumstances, the fund will invest at least 80% of its total assets (exclusive of collateral held from securities lending) in the components of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities (e.g., depositary receipts).
The index uses an objective, rules-based methodology to provide exposure to global companies with high dividend yields backed by a high free cash flow yield.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 2.60% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.43% |
| BTI | British American Tobacco p.l.c. | Consumer Defensive | Tobacco | 2.42% |
| BP | BP PLC | Energy | Oil & Gas Integrated | 2.27% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.24% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.23% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.20% |
| RIO | Rio Tinto PLC | Basic Materials | Other Industrial Metals & Mining | 2.19% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.18% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.15% |
| ENGI | Engie S.A. | Utilities | Utilities - Diversified | 2.13% |
| BATS | British American Tobacco PLC | Consumer Defensive | Tobacco | 2.12% |
| L3H | SHELL PLC WI ADR/2 | Energy | Oil & Gas Integrated | 2.11% |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 2.11% |
| PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 2.08% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 2.08% |
| MBG | Mercedes-Benz Group AG | Consumer Cyclical | Auto Manufacturers | 2.07% |
| SHEL | Shell plc | Energy | Oil & Gas Integrated | 2.01% |
| TTE | TotalEnergies SE ADR | Energy | Oil & Gas Integrated | 2.01% |
| RHHBY | Roche Holding Ltd ADR | Healthcare | Drug Manufacturers - General | 2.01% |